Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „respect“
Suchtreffer
Begriffe & Kennungen
Dynastat · 4.5 · Plasma exposure (AUC and Cmax) to valdecoxib was increased (38% and 24%, respectively) when coadministered wit
Eintrag öffnenDynastat · 4.5 · Plasma exposure (AUC and Cmax) to valdecoxib was increased (62% and 19%, respectively) when coadministered wit
Eintrag öffnenDynastat · 4.5 · Plasma exposure (AUC and Cmax) to valdecoxib was increased (62% and 19%, respectively) when coadministered wit
Eintrag öffnenEdurant · 4.8 · 33 in the rilpivirine arm and efavirenz arm was 104.3 and 104.1 weeks, respectively. Most ADRs occurred in the
Eintrag öffnenEntecavir Accord · 4.8 · Gender/age: there was no apparent difference in the safety profile of entecavir with respect to gender ( 25%
Eintrag öffnenEntecavir Viatris (previously Entecavir Mylan) · 4.8 · Gender/age There was no apparent difference in the safety profile of entecavir with respect to gender (≈ 25% w
Eintrag öffnenEpoetin Alfa Hexal · 4.3 · - All contraindications associated with autologous blood predonation programmes should be respected in patient
Eintrag öffnenErbitux · 4.8 · When cetuximab is used in combination with chemotherapeutic agents, also refer to their respective product inf
Eintrag öffnenFarydak · 4.8 · Fatigue and asthenia Fatigue and asthenia were reported in 41.2% and 22.0% of patients, respectively. CTC grad
Eintrag öffnenFendrix · 4.8 · No increase in the reactogenicity was observed after the booster vaccination with respect to the primary vacci
Eintrag öffnenFlebogamma DIF (previously Flebogammadif) · 4.8 · For safety information with respect to transmissible agents, see section 4.4.
Eintrag öffnenFlebogamma DIF (previously Flebogammadif) · 4.8 · For safety information with respect to transmissible agents, see section 4.4.
Eintrag öffnenFoclivia · 4.8 · Irrespective of antigen dose, antigen subtype or age group, most local and systemic adverse reactions after ad
Eintrag öffnenFoclivia · 4.8 · Irrespective of antigen dose, antigen subtype or age group, most local and systemic adverse reactions after ad
Eintrag öffnenGlivec · 4.5 · Imatinib increases the mean Cmax and AUC of simvastatin (CYP3A4 substrate) 2- and 3.5-fold, respectively, indi
Eintrag öffnenGrepid · 4.8 · 9 + ASA group and 0.7 % in the placebo +ASA group) and hemorrhagic stroke (0.8 % and 0.6 %, respectively) betw
Eintrag öffnenHalaven · 4.8 · 8 307/404 (76.0%) and 1314/1559 (84.3%), respectively. The median duration of treatment was 12.0 weeks for sar
Eintrag öffnenHizentra · 4.8 · 7 For safety with respect to transmissible agents, see section 4.4.
Eintrag öffnenHyQvia · 4.8 · For safety with respect to transmissible agents, see section 4.4.
Eintrag öffnenHyQvia · 4.8 · Post-authorisation safety studies (EU 161302, US 161406) included 15 and 77 elderly subjects, respectively. Ov
Eintrag öffnen